Evidence map›Paper›PMID 39268202›Full record

ArticleProceedings of SPIE--the International Society for Optical Engineering2024

Nucleus subtype classification using inter-modality learning.

Lucas W Remedios, Shunxing Bao, Samuel W Remedios, Ho Hin Lee, Leon Y Cai, Thomas Li, Ruining Deng, Can Cui, Jia Li, Qi Liu and 7 more

Abstract read
In one paragraph

Article in Proceedings of SPIE--the International Society for Optical Engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Identifying Cellular Neighborhood Phenotypes Differentiating Normal and Quiescent Crohn's Disease via MxIF.Proceedings of SPIE--the International Society for Optical Engineering · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Lucas W RemediosVanderbilt University, Department of Computer Science, Nashville, USA.
Shunxing BaoVanderbilt University, Department of Electrical and Computer Engineering, Nashville, USA.
Samuel W RemediosJohns Hopkins University, Department of Computer Science, Baltimore, USA.
Ho Hin LeeVanderbilt University, Department of Computer Science, Nashville, USA.
Leon Y CaiVanderbilt University, Department of Biomedical Engineering, Nashville, USA.
Thomas LiVanderbilt University, Department of Biomedical Engineering, Nashville, USA.
Ruining DengVanderbilt University, Department of Computer Science, Nashville, USA.
Can CuiVanderbilt University, Department of Computer Science, Nashville, USA.
Jia LiVanderbilt University Medical Center, Department of Biostatistics, Nashville, USA.
Qi LiuVanderbilt University Medical Center, Department of Biostatistics, Nashville, USA.
Ken S LauVanderbilt University Medical Center, Center for Quantitative Sciences, Nashville, USA.
Joseph T RolandVanderbilt University Medical Center, Epithelial Biology Center, Nashville, USA.
Mary K WashingtonVanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology, Nashville, TN, USA.
Lori A CoburnVanderbilt University Medical Center, Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Nashville, USA.
Keith T WilsonVanderbilt University Medical Center, Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Nashville, USA.
Yuankai HuoVanderbilt University, Department of Computer Science, Nashville, USA.
Bennett A LandmanVanderbilt University, Department of Computer Science, Nashville, USA.

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
Medical Scientist Training ProgramT32GM152284 · NIGMS · VANDERBILT UNIVERSITY · PI Christopher S. Williams · 2024 to 2026
$4.8M
Tuft cell heterogeneity in function, lineage, and structure in ileal inflammatory diseaseR01DK103831 · NIDDK · VANDERBILT UNIVERSITY · PI LAU, KEN S · 2016 to 2024
$4.4M
Integrated Training in Engineering and DiabetesT32DK101003 · NIDDK · VANDERBILT UNIVERSITY · PI Jamey D. Young · 2014 to 2026
$3.9M
Spermidine as a New Therapy for Colitis and Chemopreventive for Colitis-associated CarcinogenesisR01DK128200 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 2021 to 2024
$2.7M
AI-empowered 3D Computer Vision and Image-Omics Integration for Digital Kidney HistopathologyR01DK135597 · NIDDK · VANDERBILT UNIVERSITY · PI Yuankai Huo · 2023 to 2026
$2.1M
CCL11 as a New Therapeutic Target for Colitis and Colon CancerI01BX004366 · VA · VETERANS HEALTH ADMINISTRATION · PI COBURN, LORI A · 2019 to 2022
–
BLRD VA I01 BX004366CSRD VA I01 CX002171CSRD VA I01 CX002473NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR002243NCRR NIH HHS UL1 RR024975NICHD NIH HHS P50 HD103537NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK103831NIDDK NIH HHS R01 DK128200NIDDK NIH HHS R01 DK135597NIDDK NIH HHS T32 DK101003NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM152284
6 · The paper itself

Abstract

Understanding the way cells communicate, co-locate, and interrelate is essential to understanding human physiology. Hematoxylin and eosin (H&E) staining is ubiquitously available both for clinical studies and research. The Colon Nucleus Identification and Classification (CoNIC) Challenge has recently innovated on robust artificial intelligence labeling of six cell types on H&E stains of the colon. However, this is a very small fraction of the number of potential cell classification types. Specifically, the CoNIC Challenge is unable to classify epithelial subtypes (progenitor, endocrine, goblet), lymphocyte subtypes (B, helper T, cytotoxic T), or connective subtypes (fibroblasts, stromal). In this paper, we propose to use inter-modality learning to label previously un-labelable cell types on virtual H&E. We leveraged multiplexed immunofluorescence (MxIF) histology imaging to identify 14 subclasses of cell types. We performed style transfer to synthesize virtual H&E from MxIF and transferred the higher density labels from MxIF to these virtual H&E images. We then evaluated the efficacy of learning in this approach. We identified helper T and progenitor nuclei with positive predictive values of 0.34 ± 0.15 (prevalence 0.03 ± 0.01) and 0.47 ± 0.1 (prevalence 0.07 ± 0.02) respectively on virtual H&E. This approach represents a promising step towards automating annotation in digital pathology.

Indexed as

annotationclassificationH&EMxIFnuclei classificationstyle transfervirtual H&Ewhole slide imaging

Identifiers

PMID39268202
PMCPMC11392413

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.